BCL-201 | m-entrepreneurship.com

Product Name :
BCL-201

Search keywords :
S55746

drugId :
null

Target Vo:
Apoptosis regulator Bcl-2

Target Vo Short Name :
BCL2

Moa_Name:
Apoptosis regulator Bcl-2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Les Laboratoires Servier

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Multiple Myeloma

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bermekimab Immunology/Inflammation
ATG10 Antibody Epigenetic Reader Domain
HSD3B1 Antibody: HSD3B1 Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-HSD3B1 polyclonal antibody. HSD3B1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in mouse, rat, and predicted: human, dog, cow, horse background without labeling.

Author: Betaine hydrochloride

Related Posts